JAMEELA KHAN: Open Payments
NPI 1194037457 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,283 in 59 payments from 20 companies in 2025. Trend: 2023 $527 · 2024 $1,013 · 2025 $1,283
Food & beverage: $1,283
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $212 |
| Amgen Inc. | 3 | $157 |
| Lilly USA, LLC | 7 | $132 |
| Exact Sciences Corporation | 7 | $118 |
| Dexcom, Inc. | 3 | $71 |
| Abbott Laboratories | 3 | $67 |
| PFIZER INC. | 3 | $60 |
| GlaxoSmithKline, LLC. | 3 | $55 |
| Boston Scientific Corporation | 3 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $54 |
Products named: IMDELLTRA (AMG757), The Cologuard Plus Collection Kit, JARDIANCE, Dexcom G6 Transmitter, FREESTYLE LIBRE 3, Wegovy, PREVNAR 20, MOUNJARO.
Industry payments across NY — which companies pay providers there.
